At its 2026 Annual Meeting, Globus Medical, Inc. stockholders approved an amendment to the 2021 Equity Incentive Plan, increasing the total authorized shares under the plan by 1,000,000 to a total of 12,000,000 shares of Class A Common Stock. The meeting also resulted in the election of two Class II directors and the ratification of Deloitte & Touche LLP as the company's independent registered public accounting firm.
